Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study Jun 15, 2023
Numinus CEO Payton Nyquvest Answers Investor Questions And Gives Look-Ahead Outlook For 2023 Dec 30, 2022
